Cause of action for selection of equivalent drug product or interchangeable biological product

The selection of an equivalent drug product or interchangeable biological product does not, in itself, in the absence of willful misconduct or negligence, constitute a cause of action against the practitioner. Source: SL 1993, ch 277 , § 7; SL 2018, ch 231 , § 8.